Financial Performance & Growth - Corteva's net sales for FY 2021 reached $1565 billion, a 10% increase[33,37] - Organic sales for FY 2021 also grew by 9%, reaching $1550 billion[39,43] - Operating EBITDA for FY 2021 increased by 11% to $262 million[45,49] - Operating EBITDA margin improved by 178 bps in FY 2021[52] - Crop Protection sales increased 12% to $7253 billion in FY2021[81] - Seed sales increased 8% to $8402 billion in FY2021[120] Regional Performance - North America reported a 5% increase in net sales in FY 2021, with organic growth of 4%[56] - EMEA reported a 10% increase in net sales in FY 2021, with organic growth of 6%[56] - Latin America reported a 3% increase in net sales in FY 2021, with organic growth of 26%[56] - Asia Pacific reported a 26% increase in net sales in FY 2021, with organic growth of 27%[56] 2022 Outlook - The company projects net sales between $167 billion and $170 billion in 2022, representing an 8% growth at the midpoint[64] - Operating EPS is projected to be between $230 and $250 in 2022, a 12% growth at the midpoint[62,64] - Free cash flow is expected to be between $13 billion and $16 billion in 2022[61]

Corteva, Inc. (NYSE:CTVA) Q4 2021 Earnings Conference Call February 3, 2022 9:00 AM ET Company Participants Jeff Rudolph - Vice President of Investor Relations Chuck Magro - Chief Executive Officer Dave Anderson - Executive Vice President & Chief Financial Officer Tim Glenn - Executive Vice President & Chief Commercial Officer Rajan Gajaria - Executive Vice President of Business Platforms Conference Call Participants Joel Jackson - BMO Capital Markets Vincent Andrews - Morgan Stanley Kevin McCarthy - Vertic ...

Financial Data and Key Metrics Changes - Corteva reported a 24% organic growth in both seed and crop protection compared to the prior year, driven by strong demand particularly in Latin America and North America [12][13] - Year-to-date organic sales increased by 9% to just over $12 billion, with EBITDA of $2.31 billion, up 25% year-over-year [14][19] - The company experienced a seasonal loss of $51 million in operating EBITDA for the quarter, an improvement of over $120 million compared to the previous year [13][14] Business Line Data and Key Metrics Changes - In North America, organic sales were up 5%, with seed sales benefiting from increased planted areas for corn and soybeans [15] - Crop protection in North America delivered a 10% year-to-date organic sales increase, with strong demand for new technologies [16] - Latin America saw a remarkable 27% organic sales growth, driven by strong volumes and price gains [17] Market Data and Key Metrics Changes - North America experienced a 2% increase in corn prices and a 3% decrease in soybean prices due to competitive pressures [15] - In Europe, the Middle East, and Africa, organic sales grew by 7%, impacted by corn supply shortages [16] - Asia-Pacific delivered 7% organic sales growth, with crop protection growing by 11% due to demand for new products [18] Company Strategy and Development Direction - The company aims to leverage its strong operational performance and customer relationships to drive long-term solutions to global agricultural issues [11] - Corteva is focused on sustainability and innovation, with a commitment to delivering value for shareholders while addressing climate change [11][39] - The management team is committed to executing the strategic plan and enhancing operational excellence [39] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the agricultural market's positive outlook for 2022, with expectations of good planted acreage in corn and soybeans [43] - The company anticipates continued supply chain challenges and cost inflation, but remains focused on pricing strategies to mitigate these impacts [21][31] - The outlook for 2021 has been raised, expecting reported net sales in the range of $15.5 to $15.7 billion, reflecting strong market fundamentals [25][26] Other Important Information - The company is raising its full-year operating EBITDA guidance to a range of $2.5 to $2.6 billion, representing a 22% improvement over 2020 [26] - Corteva is also increasing its free cash flow guidance to a range of $550 million, reflecting improved operational disciplines [50][51] Q&A Session Summary Question: Insights from a new CEO's perspective on Corteva's strengths and areas for improvement - The new CEO expressed positive early impressions of the company's operations and emphasized the importance of customer focus and sustainability initiatives [35][36][39] Question: Confidence in achieving 2022 targets - The CEO reaffirmed confidence in the management team and the positive agricultural backdrop, indicating potential for long-term value creation [42][43] Question: Growth potential of the biologics business - The management highlighted the importance of unique technology and strong commercial capabilities in driving growth in the biologics sector [46][49] Question: Drivers of increased free cash flow guidance - The CFO explained that improved working capital management and operational disciplines contributed to the increased cash flow guidance [51][54] Question: Pricing strategies in response to competitive pressures - The management discussed proactive pricing strategies to capture value and mitigate inflationary pressures in both seed and crop protection segments [60][64]

| --- | --- | --- | |-------|-----------------------------------|-------| | | | | | | 3Q 2021 Earnings Conference Call | | | | November 4, 2021 | | Safe Harbor Regarding Forward-Looking Statements 2 Forward-Looking Statements This presentation contains certain estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions fo ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share CTVA New York Stock Exchange UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38 ...

| --- | --- | --- | |-------|----------------------------------------|-------| | | | | | | 2Q & 1H 2021 Earnings Conference Call | | | | August 6, 2021 | | Safe Harbor Regarding Forward-Looking Statements 2 Forward-Looking Statements This presentation contains certain estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provi ...

Corteva, Inc. (NYSE:CTVA) Q2 2021 Results Conference Call August 6, 2021 9:00 AM ET Company Participants Jeff Rudolph - Investor Relations Jim Collins - Chief Executive Officer Dave Anderson - Executive Vice President, Chief Financial Officer Tim Glenn - Executive Vice President, Chief Commercial Officer Rajan Gajaria - Executive Vice President of Business Platforms Conference Call Participants Joel Jackson - BMO Capital Markets Vincent Andrews - Morgan Stanley Kevin McCarthy - Vertical Research Partners P ...

Table of Contents Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share CTVA New York Stock Exchange UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 C ...

Summary of Corteva, Inc. Conference Call Company Overview - **Company**: Corteva, Inc. (NYSE:CTVA) - **Event**: Deutsche Bank's 12th Annual Global Basic Materials Conference - **Date**: June 9, 2021 - **Participants**: Jim Collins (CEO), Dave Begleiter (Deutsche Bank) Key Industry Insights - **Agricultural Fundamentals**: Strong fundamentals in agriculture with corn and soybean prices reaching near seven-year highs [3][4] - **Grain Supply Outlook**: Difficulties in rebuilding global supplies of grains and oilseeds due to drought conditions in Latin America and strong demand, particularly from China [7][8] - **Multi-Year Cycle**: Expectation of a multi-year cycle of stronger grain prices, driven by demand and supply constraints [8] Company Performance and Strategy - **Momentum and Execution**: Corteva finished 2020 strong and carried that momentum into 2021, focusing on execution amidst global challenges [4][5] - **Strategic Focus**: Key components of Corteva's strategy include top-line growth in Crop Protection and seeds, margin enhancement, and disciplined capital allocation [5][6] - **Market Positioning**: Confident in creating shareholder value through strategic execution and capitalizing on strong agricultural market fundamentals [7] Pricing and Market Dynamics - **Price Projections**: Anticipated easing of corn and soybean prices in 2022 and 2023, but still at constructive levels that support net farm income [10] - **Farmer Purchasing Behavior**: Higher prices are expected to lead farmers to invest more in seeds and crop protection applications [12][13] Product Development and Innovations - **Enlist System**: Strong momentum in the Enlist system with expectations of significant market penetration [21][22] - **Qrome Product**: Projected sales of $800 million in 2021, with a potential peak sales target of $1.1 billion [26][27] - **Brevant Brand**: Successful launch with goals to achieve 20% market share, representing a $200 million incremental earnings opportunity [31][32] Crop Protection and Market Trends - **New Products**: Progress in new Crop Protection products with expectations of $1.3 billion in sales from the pipeline [43] - **Insect and Disease Pressure**: Normal year for insect pressure, with strong performance in soybean herbicides due to glyphosate shortages [45] Cost Management and Inflation - **Inflation Pressures**: Rising costs in raw materials, particularly glyphosate, leading to price adjustments [47][48] - **Productivity Actions**: Ongoing efforts to offset cost headwinds through productivity improvements and pricing strategies [50][52] Financial Outlook - **EBITDA Guidance**: Confidence in maintaining EBITDA guidance despite cost pressures [52] - **Pension Liability**: US pension plan was 84% funded as of the end of 2020, with no required contributions expected [64][65] M&A Strategy - **Growth Strategy**: Focus on opportunistic M&A to enhance product offerings and geographic footprint, particularly in biologicals and digital platforms [62][63] Conclusion - **Overall Sentiment**: Corteva is well-positioned to navigate current market dynamics, with a strong focus on execution, innovation, and strategic growth initiatives [7][8][9]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-38710 Corteva, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 82-4979096 (State or other Jurisdiction of Incorporation or Organizatio ...